about
A randomised controlled trial of triple antiplatelet therapy (aspirin, clopidogrel and dipyridamole) in the secondary prevention of stroke: safety, tolerability and feasibilityInterventions for deliberately altering blood pressure in acute strokePublication bias in reports of animal stroke studies leads to major overstatement of efficacyEffects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second StrokesAspirin and extended-release dipyridamole versus clopidogrel for recurrent strokeEarly dual versus mono antiplatelet therapy for acute non-cardioembolic ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysisBlood pressure and clinical outcomes in the International Stroke TrialEffect of aspirin, clopidogrel and dipyridamole on soluble markers of vascular function in normal volunteers and patients with prior ischaemic strokeBleeding time, stroke and myocardial infarction: the Caerphilly prospective studyFurther characterisation of a thromboembolic model of stroke in the ratDipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trialsIs there a link between aspirin therapy and stroke severity?Effects of aspirin, clopidogrel and dipyridamole administered singly and in combination on platelet and leucocyte function in normal volunteers and patients with prior ischaemic strokeStroke severity, early recovery and outcome are each related with clinical classification of stroke: data from the 'Tinzaparin in Acute Ischaemic Stroke Trial' (TAIST)Early recovery and functional outcome are related with causal stroke subtype: data from the tinzaparin in acute ischemic stroke trialRelationship between outcome and baseline blood pressure and other haemodynamic measures in acute ischaemic stroke: data from the TAIST trialSex differences in quality of life in stroke survivors: data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST)Low molecular weight heparin versus aspirin for acute ischemic stroke: a systematic reviewTriple antiplatelet therapy for secondary prevention of recurrent ischemic strokeCompression stockings and the prevention of symptomatic venous thromboembolism: data from the Tinzaparin in Acute Ischemic Stroke TrialTargeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials.Very low quality of life after acute stroke: data from the Efficacy of Nitric Oxide in Stroke trial.Views of paramedics on their role in an out-of-hospital ambulance-based trial in ultra-acute stroke: qualitative data from the Rapid Intervention With Glyceryl Trinitrate in Hypertensive Stroke Trial (RIGHT).Relationship between poststroke cognition, baseline factors, and functional outcome: data from "efficacy of nitric oxide in stroke" trial.Individual patient data meta-analysis of randomized controlled trials of community occupational therapy for stroke patients.Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review.Sample size calculations in acute stroke trials: a systematic review of their reporting, characteristics, and relationship with outcome.Association between hormone replacement therapy and subsequent stroke: a meta-analysis.Effect of nitric oxide donors on blood pressure and pulse pressure in acute and subacute stroke.Predicting long-term outcome after acute ischemic stroke: a simple index works in patients from controlled clinical trials.Stroke outcome in clinical trial patients deriving from different countries.The relationship between baseline blood pressure and computed tomography findings in acute stroke: data from the tinzaparin in acute ischaemic stroke trial (TAIST).Triple antiplatelet therapy for preventing vascular events: a systematic review and meta-analysis.Relationship between hyperacute blood pressure and outcome after ischemic stroke: data from the VISTA collaboration.Interconversion of the National Institutes of Health Stroke Scale and Scandinavian Stroke Scale in acute stroke.Acute strokeSecondary prevention of transient ischemic attack and strokeRemote Assessment of Platelet Function in Patients with Acute Stroke or Transient Ischaemic AttackRelationship between baseline blood pressure parameters (including mean pressure, pulse pressure, and variability) and early outcome after stroke: data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST).Quality of life after ischemic stroke varies in western countries: data from the tinzaparin in Acute Ischaemic Stroke Trial (TAIST).
P50
Q21144269-2833AB08-7B8F-4EE1-AE9B-A8DFC57CB8EAQ24241232-77D23DAF-07E1-4CAC-8E78-5F7F99FEB2E9Q24273209-234A117E-78A4-4BFE-BECC-5E1B21CF782DQ24645205-553EDCE3-41AE-459E-A274-F1DC2EBA9286Q24646522-47874782-D856-4099-9F8E-48DDF165F6E0Q27000619-73991C82-0D9C-4950-9626-F5857DA8B062Q28192922-8736A72E-73E6-4492-876C-FAF3064D1841Q28194573-F056BE5B-D65E-4E46-9D2E-70417E3618BBQ28196675-706FA56C-F12B-4A7F-94BC-709F8FEAFF83Q28205784-3897796F-7BD2-42C9-99C7-722241122B79Q28210915-50E6726B-AB55-4FB9-902A-6280ED44D39CQ28213824-3A6C4FDF-5780-49A6-BCC4-96EC6B95EA9BQ28218268-327FF593-0F8C-4670-8DCB-712BCA1C847AQ28218406-A9D899DE-C2B2-42A4-8F52-A1D87128F018Q28219299-63FE6E29-7DBB-4BC3-A848-4B40B484A9FBQ28219416-1D6B842E-0C6C-4361-8C3D-743DEAAD8E6BQ28222272-4E2E522B-D12B-4B6A-AC64-B2A2D1FE9FF2Q28222314-BBE7CFE0-9F68-45C3-87DC-2E8E000A6941Q28222322-FF230634-A446-4F87-A8E3-E54A412E98C5Q28222335-2A4DC689-D641-4F4B-A9E4-F49DA42C5BCEQ30621033-F67C1525-1816-4453-BEA4-034DBF7EE333Q30682304-6454FC3D-833F-411E-8735-1154A676FB5CQ30804339-459F90E9-D929-4A30-926B-367B2793836EQ30832922-906AC099-BEB8-4D4E-B221-32C190802005Q30946846-30B060F4-63E3-4611-B200-E413813CF93AQ31016789-03DF1EDC-CFFD-40CA-9384-B6B038DF69A3Q33199832-71701C11-AC9F-4B60-B4B6-D5A0100BF7C8Q33210702-69ED5F5D-E3AE-46B2-B664-123CD17F3950Q33300843-577AC899-DF3E-4D64-8D0F-E3D23ECFE087Q33327657-6479AB5C-67FF-4827-9020-D4ED14196BA0Q33377419-B0E8F70B-3AE0-4D18-A964-8C5D74573495Q33383120-687D444C-81B6-4079-85AD-6CFE0FBBE4CEQ33390176-EE7B58A1-3DD7-43EB-B557-5F5172470261Q33428930-E36289FC-49FA-43C2-B272-6864D678C973Q33515640-2BD2E5A2-6DCA-4D60-B6FD-592B0F7B7E79Q33728148-1C47541A-5674-4008-9AAE-343995E74C45Q33728218-6CA5CC13-6AA8-44C9-8C0F-36E03A4CB1A6Q33775718-EB8F15E1-2C2C-428A-8CC8-A9D0DDACB737Q33779919-161E7351-65C7-4DE4-80EA-0637AAB781EAQ33841576-5C8FBF66-0517-4D51-9DF5-EFA1C5C75786
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Philip M W Bath
@ast
Philip M W Bath
@en
Philip M W Bath
@es
Philip M W Bath
@nl
Philip M W Bath
@sl
type
label
Philip M W Bath
@ast
Philip M W Bath
@en
Philip M W Bath
@es
Philip M W Bath
@nl
Philip M W Bath
@sl
prefLabel
Philip M W Bath
@ast
Philip M W Bath
@en
Philip M W Bath
@es
Philip M W Bath
@nl
Philip M W Bath
@sl
P214
P1053
F-9020-2011
P106
P1153
24723490800
P21
P214
P31
P3829
P496
0000-0003-2734-5132
P735
P7859
viaf-311800026